about
sameAs
Trends and advances in tumor immunology and lung cancer immunotherapyThe ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte.Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycleAutoimmunity and vascular involvement in systemic sclerosis (SSc).Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions.Familial hemophagocytic lymphohistiocytosis: too little cell death can seriously damage your health.Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes.Cell death in the peripheral nervous system: potential rescue strategies.Prospects for immune reconstitution in HIV-1 infection.Cytolytic pathways in haematopoietic stem-cell transplantation.Reciprocal complementation of the tumoricidal effects of radiation and natural killer cellsA critical review of T cell targeting immunotherapy in pancreatic cancer: only a hypothesis or a real hope for the patients?The role of CD8+ T cells during allograft rejection.Immunosuppressive tumor microenvironment in cervical cancer patientsExploiting natural anti-tumor immunity for metastatic renal cell carcinoma.Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis.Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond.Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax.Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity.Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasionA potential role for CD8+ T-cells as regulators of CNS vascular permeability.The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis.Advances in the understanding of acute graft-versus-host disease.Mechanisms of granule-dependent killing.The great balancing act: regulation and fate of antiviral T-cell interactionsCytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease.Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.Cytolytic CD4(+) T cells in viral immunityImmune responses to West Nile virus infection in the central nervous system.CD8 and CD4 T cells in west nile virus immunity and pathogenesis.Sequential gene expression profiling in the mouse spleen during 14 d feeding with Lactobacillus brevis KB290.Profile of expression of certain markers of apoptosis in chronic hepatitis C and hepatitis B patients in an Egyptian population.Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
P2860
Q28067674-FB97D2EB-D4F1-4508-B914-794940CDF3B3Q33200018-122D4FF1-7F12-46D7-8131-585F324D9BDFQ33654414-685BE8A1-27F1-4ED8-84F9-936F06A2D485Q33876515-794724E7-7FED-4B6D-BE64-DCE128548BC5Q34119107-952F20DB-490D-48A4-9B48-CDE3942471C9Q34431456-63F22A53-B504-4696-9024-8A96CBA5EAD3Q34459401-F6AA5B62-83EF-45BB-876E-0E96BE42EC9AQ34516547-20C45B52-BB1D-482B-807B-E8A5FB2181ECQ34529394-8970343D-1D9C-48AB-85DD-D2F3DD48E495Q34609562-F7BBCA6F-62F6-49EF-9752-B676780C0674Q34632083-E401F0E0-F0AD-4612-AFEB-36393C457EA7Q34698158-AE4CAF7F-BC01-4BEB-9BEA-F1D24B1190B5Q34974725-60809F4D-0C9E-48F3-8A1D-1F8FCDF03E5AQ34994128-0FE53214-DE65-481A-BB58-FBF4580D87D7Q35603131-BF94654F-2624-4089-A48E-2E8B9D9B2ABDQ35887319-8BA269C6-BF6F-47F4-B204-8FBA81C4FEA5Q36015036-E5DF45DD-F05E-4F28-B867-0AA01BAA3929Q36228495-42AB8DB8-1C63-411A-AAF6-C269370A655EQ36266461-9DF92CB8-A61C-49EF-B977-43B97371F46AQ36368546-6EDCD373-3F48-4304-A1F4-9E0716445189Q36368907-E9EA3805-62EA-4B95-945D-816D4EB4EF8BQ36375304-1D74151B-46DC-408B-9DC4-C9068FFC833EQ36375454-1A6C42DA-F975-47E1-84BB-2E05A8C71F99Q36474325-40863739-2A9A-473E-ACF5-6C751FC6A08AQ36474330-49BA2C1E-7220-4E2D-ADCD-C11436E88A57Q36759581-E4AE7458-771A-4175-B703-4E665FCBAB7AQ36988144-FB6209B5-6E29-440A-80BF-38EE64F81D93Q37108443-554EC6DC-B345-41E3-8344-49BC5361139CQ37512187-6C6DFFA8-7097-4E54-9E0A-6A65B924040DQ37618482-D7126834-A9BF-4AA8-9F09-CF910352B42FQ37773234-E7F0B77B-7B6A-46A2-95BB-E4D82646EC83Q37812127-B38091C1-A20B-422E-AD0C-F55D068554F5Q38068093-3028853B-C202-4D26-9C3C-A4B9DBBA9CBDQ38155043-28ED7A40-465C-4984-946F-3BF70655CEA2Q38479229-2AECF091-D25E-4861-87A7-CE1337DF3B35Q38986522-6693BBEA-02E8-41BF-8990-87F793F4663BQ39136367-736005D0-1C84-4ADB-AEB2-CB4A0379A460Q39312652-943940C8-6520-4E45-AE2C-7604CBDE5E6BQ39804008-B2985460-1A20-4C80-8C90-CDFA4EBF61D9Q40413257-A2671DB3-93C6-43A9-A293-66E56B31DD49
P2860
description
im Oktober 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 1998
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1998
@uk
name
How do cytotoxic lymphocytes kill their targets?
@en
How do cytotoxic lymphocytes kill their targets?
@nl
type
label
How do cytotoxic lymphocytes kill their targets?
@en
How do cytotoxic lymphocytes kill their targets?
@nl
prefLabel
How do cytotoxic lymphocytes kill their targets?
@en
How do cytotoxic lymphocytes kill their targets?
@nl
P2093
P1476
How do cytotoxic lymphocytes kill their targets?
@en
P2093
P304
P356
10.1016/S0952-7915(98)80227-6
P577
1998-10-01T00:00:00Z